Bruker Corporation · NASDAQ:BRKR
Bruker — Non-Deal Roadshow (April 2009)
27 slides from Bruker's roadshow presentation, Apr 16, 2009
Slide 1: Bruker Corporation (BRKR) Overview
© Copyright 2009 Bruker Corporation. All Rights Reserved. 1 Bruker Corporation (BRKR) Overview JPMorgan Non-Deal Roadshow New York, April 16, 2009 Frank Laukien, President & CEO William Knight, CFO Stacey Desrochers, Treasurer & IR Director
Slide 2: Safe Harbor Statement
© Copyright 2009 Bruker Corporation. All Rights Reserved. 2 Bruker Corporation Safe Harbor Statement Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act o
Slide 3: Bruker Corporation Today: Life Sciences & Analytical
© Copyright 2009 Bruker Corporation. All Rights Reserved. 3 Bruker Corporation Today: Life Sciences & Analytical Scientific Instrumentation, Superconducting Wires & Devices High-Performance Technology Platforms Bruker AXS Materials Research & Elemental Analysis • X-ray Diffraction • X-ray Crystallog
Slide 4: Global Company with Diversified Markets
© Copyright 2009 Bruker Corporation. All Rights Reserved. 4 Global Company with Diversified Markets Excellent Reputation in High-Performance Scientific Instruments and Solutions Other Significant R&D, Production Sites Direct Sales Offices Major DE, CH & FR R&D and Production Sites Additional distrib
Slide 5: Breakdown of 2008 Revenue
© Copyright 2009 Bruker Corporation. All Rights Reserved. 5 Breakdown of 2008 Revenue Bruker Can Weather a Severe Recession Pharma Biotech IVD Companies 12% Government 11% Industrial & Applied Markets 20% Academia, Medical Schools & Non-profit 57% 2008 Annual Revenue: $1.1 Billion Revenue by Custome
Slide 6: Key Financials & Revenue Growth
© Copyright 2009 Bruker Corporation. All Rights Reserved. 6 Growth and Margins Key Financials & Revenue Growth BRKR 2008 Financials (see appendix for non-GAAP reconciliation) • Revenue $1.1B ($1.03B in 2007) • 7% GAAP growth (3% FX-adjusted) • Adj. EBITDA $170M ($196M in 2008) • Non-GAAP EPS $0.47 (
Slide 7: Profitability & Margin Opportunities
© Copyright 2009 Bruker Corporation. All Rights Reserved. 7 Growth and Margins Profitability & Margin Opportunities (see appendix for non-GAAP reconciliation) • Bruker BioSpin and Bruker Optics are the two oldest, by now market-leading, and quite profitable Bruker divisions. They strive for incremen
Slide 8: Bruker's Philosophy and Vision
© Copyright 2009 Bruker Corporation. All Rights Reserved. 8 1. Bruker makes major, long-term investments for quantum leaps in technology and capabilities • Leadership in innovation, major investment in R&D • Leading market positions in key segments 2. Bruker is a fast growing company with high margi
Slide 9: Bruker BioSpin's Leadership in NMR Spectroscopy
© Copyright 2009 Bruker Corporation. All Rights Reserved. 9 Quantum Jumps in Performance Bruker BioSpin’s Global Technology and Market Leadership in NMR Spectroscopy • November 2008: Saudi KAUST order of 10 NMR systems for ~$20M • 2 New High Field NMR Magnet introductions at ENC 2009 • world’s highe
Slide 10: World's First Solid State DNP-NMR Spectrometer
© Copyright 2009 Bruker Corporation. All Rights Reserved. 10 Quantum Jumps in Performance World’s First Solid State DNP-NMR Spectrometer with >50x Signal Enhancement Factor! • World’s first Commercial solid state Dynamic Nuclear Polarization (DNP)-NMR spectrometer, co-developed with MIT • Polarizati
Slide 11: Bruker BioSpin's Leadership in Research MRI
© Copyright 2009 Bruker Corporation. All Rights Reserved. 11 Quantum Jumps in Performance Bruker BioSpin’s Global Technology and Market Leadership in Research MRI • Pioneered actively-shielded, refrigerated superconducting pre-clinical MRI magnets • Collaboration with Siemens Medical on ClinScan™ pr
Slide 12: Revolution in Mass Spectrometry: maXis UHR-TOF
© Copyright 2009 Bruker Corporation. All Rights Reserved. 12 Quantum Jumps in Performance Revolution in Mass Spectrometry maXis™ UHR-TOF launched at ASMS 2008 Bruker has ‘rewritten the book’ with UHR-TOF technology • Ultra-high resolution 40-60k • Broad mass range and high mass • Mass accuracy in MS
Slide 13: X-ray Revolution: Superior Detection Limits with XFlash SDD
© Copyright 2009 Bruker Corporation. All Rights Reserved. 13 Quantum Jumps in Performance X-ray Revolution: Superior Detection Limits with Proprietary XFlash® SDD in Various New XRF Systems PITTCON 2008 Editor’s Bronze Award Winner S2 PICOFOX TXRF for Trace Analysis 2008 5000 Series EDS Microanalysi
Slide 14: X-ray Revolution: High-Performance Systems for Broader Markets
© Copyright 2009 Bruker Corporation. All Rights Reserved. 14 Quantum Jumps in Performance X-ray Revolution: Unique, High-Performance Systems for Broader Markets and New Users 2008 PITTCON Editor’s Gold and R&D 100 Award Winner SMART X2S World’s First Fully Automated Molecular Structure Machine NEW-2
Slide 15: Bruker Acquires Atomic Force Microscopy Company
© Copyright 2009 Bruker Corporation. All Rights Reserved. 15 New Opportunities: Bruker Acquires Atomic Force Microscopy (AFM) Company in August 2008 for Nanotechnology • Well-established method for ultra-high spatial resolution surface imaging • Materials research applications like semiconductors, d
Slide 16: Bruker Detection Division in CBRNE Detection
© Copyright 2009 Bruker Corporation. All Rights Reserved. 16 New Opportunities: Bruker Detection Division in CBRNE Detection for Defense and Homeland Security • New IMS explosives detection products launched in 2009 • Large Opportunity in CWA/TIC Facilities Monitoring (DHS Phase III) NEW: DEtector™
Slide 17: Bruker Advanced Supercon Business
© Copyright 2009 Bruker Corporation. All Rights Reserved. 17 • Advanced low-temperature superconducting (LTS) wires for clinical MRI, NMR, EPR and FTMS magnets • LTS wires for magnets used in physics accelerators or nuclear fusion projects • Medium-temperature superconductors (MTS) MgB2 wires for fu
Slide 18: Superconductors and Supercon Devices; ACCEL Acquisition
© Copyright 2009 Bruker Corporation. All Rights Reserved. 18 New Opportunities: Bruker Advanced Supercon Business Superconductors and Supercon Devices March 2009: Bruker and Nexans Successfully Complete EU Superconducting Cable Project • Bruker is developing more efficient, flexible and reliable ene
Slide 19: MALDI-TOF MS Based Edmass Solution
© Copyright 2009 Bruker Corporation. All Rights Reserved. 19 New Opportunities: MALDI-TOF MS Based Edmass™ Solution Next-Gen Protein Sequencing! • MALDI In-Source-Decay Mass Spectrometry • A single Edmass™ spectrum can provides for sequence calls of >80 a.a. residues in seconds • Both N- and C-termi
Slide 20: Complete Molecular Confidence Integrated Solution
© Copyright 2009 Bruker Corporation. All Rights Reserved. 20 New Opportunities: Complete Molecular Confidence™ Integrated Solution for Chemistry & Metabolomics Integrated Sample Submission and Tracking NMR and Exact Mass MS Molecular Profile Report Additional Techniques: SCD, FT-IR • a major step to
Slide 21: Japan National Police Agency Order for 51 Mass Spectrometers
© Copyright 2009 Bruker Corporation. All Rights Reserved. 21 New Opportunities: Japan National Police Agency (NPA) Order for 51 Mass Spectrometers for Forensics • In late 2008, the Japanese National Police Agency (NPA) signed a $12M contract (from supplementary budget) for 51 Bruker micrOTOF II ESI-
Slide 22: Bruker MALDI Molecular Imager
© Copyright 2009 Bruker Corporation. All Rights Reserved. 22 New Opportunities: Bruker MALDI Molecular Imager™ MALDI Tissue Imaging and Molecular Histology Complete MALDI Molecular Imaging Solution: • For proteins, peptides, lipids based on MALDI-TOF • New: FTMS Imaging of drugs and metabolites in t
Slide 23: Bruker Corporation www.bruker.com
www.bruker.com Bruker Corporation
Slide 24: GAAP Reconciliation: Operating Income
© Copyright 2009 Bruker Corporation. All Rights Reserved. 24 Growth and Margins GAAP Reconciliation We believe the inclusion of the non-GAAP measures helps investors to gain a better understanding of our core operating results and future prospects, consistent with how management measures and forecas
Slide 25: GAAP Reconciliation: Net Income
© Copyright 2009 Bruker Corporation. All Rights Reserved. 25 Growth and Margins GAAP Reconciliation We believe the inclusion of the non-GAAP measures helps investors to gain a better understanding of our core operating results and future prospects, consistent with how management measures and forecas
Slide 26: GAAP Reconciliation: EBITDA
© Copyright 2009 Bruker Corporation. All Rights Reserved. 27 Growth and Margins GAAP Reconciliation We believe the inclusion of the non-GAAP measures helps investors to gain a better understanding of our core operating results and future prospects, consistent with how management measures and forecas
Slide 27: GAAP Reconciliation: Footnotes
© Copyright 2009 Bruker Corporation. All Rights Reserved. 28 Growth and Margins GAAP Reconciliation (a) “GAAP” (Reported) results were determined in accordance with United States Generally Accepted Accounting Principles (GAAP). (b) Results in 2008 and 2007 include charges associated with the acquisi